1. Home
  2. MOBX vs BDSX Comparison

MOBX vs BDSX Comparison

Compare MOBX & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobix Labs Inc.

MOBX

Mobix Labs Inc.

HOLD

Current Price

$0.56

Market Cap

52.0M

Sector

N/A

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$7.79

Market Cap

53.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOBX
BDSX
Founded
2020
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.0M
53.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MOBX
BDSX
Price
$0.56
$7.79
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
1.1M
57.5K
Earning Date
12-19-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,984,000.00
$80,173,000.00
Revenue This Year
N/A
$20.75
Revenue Next Year
N/A
$25.05
P/E Ratio
N/A
N/A
Revenue Growth
180.13
22.29
52 Week Low
$0.40
$3.44
52 Week High
$2.47
$32.20

Technical Indicators

Market Signals
Indicator
MOBX
BDSX
Relative Strength Index (RSI) 46.13 51.69
Support Level $0.43 $7.68
Resistance Level $0.50 $8.17
Average True Range (ATR) 0.06 0.66
MACD 0.02 0.02
Stochastic Oscillator 80.88 55.68

Price Performance

Historical Comparison
MOBX
BDSX

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: